An Open-Label Phase I Study of the Safety and Efficacy of RAD001 in Combination with Lenalidomide in the Treatment of Patients with Relapsed and Relapsed/Refractory Multiple Myeloma.

Autor: Raje, Noopur, Richardson, Paul, Hari, Parameswaran N, Mahindra, Anuj, Kaster, Sarah *, Connolly, Christine *, Rivera, Linda *, Chetri, Gaurav *, Dean, Sarah *, Jacobs, Paulette *, Saad, Ayman, Laubach, Jacob *, Ghobrial, Irene M., Schlossman, Robert L, Adams, Jennifer *, Makrides, Wendy *, Weller, Edie *, Munshi, Nikhil, Anderson, Kenneth C.
Zdroj: In Blood 20 November 2009 114(22):3856-3856
Databáze: ScienceDirect